Articles
March 05, 2024
Advancing Equitable Vaccine Access: mRNA Technology Transfer Program’s Role in Democratizing Vaccine Development and Production.
Table of Contents
Other articles
December 11, 2023
Novel continuous RNA manufacturing process could pave the way for personalized neoantigens cancer treatments
September 11, 2023
Univercells’ presence in the World’s biotech hub: a significant leap for RNA vaccine manufacture
September 11, 2022
Univercells wins the Wallonie Bruxelles International Sustainability Award
Share